Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil adjunctive therapy for bipolar I depression
2010-023623-26Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder and bipolar disorder (BD) comparing Armodafinil adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2011; status: completed.
02
Drugs
armodafinil
03
Conditions
bipolar I disorderbipolar disorder (BD)
Beyond the preview
Go deeper on 2010-023623-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023623-26.